Advertisement

Topics

Wuxi syder Bio-products Co., Ltd Company Profile

16:38 EDT 22nd September 2017 | BioPortfolio

Wuxi syder Bio-products Co., Ltd is located at Xishan Economic & Technological Development Zone, Our main products are Syder Brand High Temperature α-amylase, Syder Brand High Conversion Efficiency Saccharifying Enzyme in Liquid and Solid Preparation,Syder Brand Kojic Acid,cellulase and Syder Brand liquefying α-amylase.

Location

Xishan Economic & Technological Development Zone
wuxi
jiangsu
214403
China

Contact

Phone: 865102699868
Fax: 865102699968


News Articles [755 Associated News Articles listed on BioPortfolio]

Chinese Premier Li Keqiang Visits WuXi PharmaTech's Headquarter in Shanghai

SHANGHAI, April 1, 2013 /PRNewswire/ -- Chinese Premier Li Keqiang visited WuXi PharmaTech's headquarter in Shanghai on March 28, 2013. The visit was part of the first research tour by the newly elect...

WuXi Biologics Licenses GLS-010 to Arcus Biosciences

WuXi Biologics will be the exclusive manufacturer for GLS-010 in the licensed territories

Wuxi AppTec says expanded STA will get drugs to market faster

Wuxi AppTec says merged development services and API business will provide customers with more integrated service. 

WuXi’s Pharmaceutical Development Services Division, STA merge

STA Pharmaceutical, a WuXi AppTec group company and an open-access capability and technology platform for small molecule pharmaceutical development and manufacturing—announces that it has merged wit...

WuXi NextCODE, a Genomics CRO, Closes $240 Million Series B Round

WuXi NextCODE completed a Series B fundraising with $240 million in new capital for its genomics CRO operations. In May, the company closed the first tranche of the round. NextCODE is WuXi AppTec's pl...

Deal Watch: WuXi/Gloria License PD-1 Inhibitor To Arcus For Up To $816m

WuXi Biologics and Harbin Gloria will get $18.5m up front for the Phase I asset GLS-010. Also, Cerecor divests depression...   

STA: merger with WuXi division follows single source contract provider trend

STA Pharmaceutical has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) to create a “more complete and integrated platform.”

Week In Review: Wuxi Biologics Raises $511 Million In Hong Kong IPO

WuXi Biologics priced its Hong Kong IPO at the top of the range, raising $511 million and valuing the biologics operations of WuXi AppTec at $3 billion; SciClone Pharma, a China drug distributor, acce...

PubMed Articles [1034 Associated PubMed Articles listed on BioPortfolio]

The evolving landscape of drug products containing nanomaterials in the United States.

The Center for Drug Evaluation and Research (CDER) within the US Food and Drug Administration (FDA) is tracking the use of nanotechnology in drug products by building and interrogating a technical pro...

Stability of bacteriophages in burn wound care products.

Bacteriophages could be used along with burn wound care products to enhance antimicrobial pressure during treatment. However, some of the components of the topical antimicrobials that are traditionall...

Bluegenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification.

Nature provides a valuable resource of medicinally relevant compounds, with many antimicrobial and antitumor agents entering clinical trials being derived from natural products. The generation of anal...

Ownership reform and the changing manufacturing landscape in Chinese cities: The case of Wuxi.

Since the economic transition, manufacturing in China has undergone profound changes not only in number of enterprises, but also in ownership structure and intra-urban spatial distribution. Investigat...

The complex dynamics of products and its asymptotic properties.

We analyse global export data within the Economic Complexity framework. We couple the new economic dimension Complexity, which captures how sophisticated products are, with an index called logPRODY, a...

Clinical Trials [790 Associated Clinical Trials listed on BioPortfolio]

Serological Screening of Gastric Cancer in Wuxi Region

The purpose of this study is to determine whether detection of pepsinogen Ⅰand Ⅱ combined with Helicobacter pylori antibody, so-called ABC method , is fit on gastric cancer screening i...

Gastrointestinal Toleration of Inulin Products

The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products. The investigators hypothesis that doses of up to 10 gram...

Human Laboratory Study of Smokeless Tobacco Products

With the advent of restrictions on public smoking, the tobacco industry has introduced a variety of novel smokeless tobacco products (NSTP) to allow continued tobacco use. These products t...

Oat Products in the Treatment of Coeliac Disease in Children

In many Northern European countries oat-based products have been used in the dieto-therapy of coeliac disease for many years. The purpose of this study is to evaluate clinical tolerance a...

Safe Water Techniques in Kenya

Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products...

Companies [385 Associated Companies listed on BioPortfolio]

Wuxi syder Bio-products Co., Ltd

Wuxi syder Bio-products Co., Ltd is located at Xishan Economic & Technological Development Zone, Our main products are Syder Brand High Temperature α-amylase, Syder Brand High Conversion Efficien...

Wuxi Syder Bio-products Co.,Ltd.

Wuxi Syder Bio-Products Co., LTD is a specialized one mainly producing Heat Stable a-Amylase. They devote themselves to making a breakthough in fermentation level, products quality and using effects. ...

WuXi PharmaTech (Cayman) Inc.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused co...

WuXi PharmaTech, Ltd.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused com...

WuXi PharmaTech

Founded in 2001 and located in WaiGaoQiao Free Trade Zone, Shanghai, WuXi PharmaTech is a research service company that provides services to support new drug discovery and the chemical development of ...

More Information about "Wuxi syder Bio-products Co., Ltd" on BioPortfolio

We have published hundreds of Wuxi syder Bio-products Co., Ltd news stories on BioPortfolio along with dozens of Wuxi syder Bio-products Co., Ltd Clinical Trials and PubMed Articles about Wuxi syder Bio-products Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Wuxi syder Bio-products Co., Ltd Companies in our database. You can also find out about relevant Wuxi syder Bio-products Co., Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...


Corporate Database Quicklinks



Searches Linking to this Company Record